Description
AmpliSeq for Illumina Comprehensive Panel v3
Targeted DNA and RNA research panel investigating variants across 161 genes associated with a range of cancer types.
AmpliSeq for Illumina Comprehensive Panel v3 Data Sheet English Data sheet HTML externalFile 1 versions
English
Assay time
Hands-on time
Input quantity
Learn
Order
Overview
Applications
Documentation
Compare
Overview
The AmpliSeq for Illumina Comprehensive Panel v3 offers coverage of key cancer genes, including kinase domains and genes involved in DNA repair.
Key features
Relevant gene content - Target 161 unique cancer-associated genes
Fast, streamlined workflow - Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality or 10 ng of formalin-fixed, paraffin-embedded (FFPE) input samples
Accurate data - Detect somatic mutations down to 5% frequency using local or cloud-based analysis
The panel content spans hotspot regions, full-length genes*, copy number genes, and inter- and intragenic gene fusions. This ready-to-use panel saves you the time and effort of identifying targets, designing primers, and optimizing panels.
The Comprehensive Panel v3 is part of an integrated workflow that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis.
*For this panel, Illumina defines full-length gene content as covering the majority of the gene’s coding regions, generally having > 90% in silico coverage and with most genes having > 99% coverage. Please refer to the provided product manifest file for further detail.
Example workflow
AmpliSeq for Illumina Comprehensive Panel v3
AmpliSeq for Illumina Library PLUS
AmpliSeq for Illumina CD Indexes
NextSeq 550 System
BaseSpace Sequence Hub DNA Amplicon App
BaseSpace Sequence Hub RNA Amplicon App
BaseSpace Sequence Hub Lab CNV App
Local Run Manager DNA Amplicon Module
Local Run Manager RNA Amplicon Module
Project recommendations
Instrument: Recommended number of samples
MiniSeq System: 3 samples per run (high output; assumes minimum coverage of 500×)
3 samples per run (high output; assumes minimum coverage of 500×)
2 × 150 bp
MiSeq System: 3 samples per run with v3 reagents (assumes minimum coverage of 500×)
3 samples per run with v3 reagents (assumes minimum coverage of 500×)
NextSeq 550 System: Samples per run: mid output: 16, high output: 48 (assumes minimum coverage of 500×)
Samples per run: mid output: 16, high output: 48 (assumes minimum coverage of 500×)
Related applications and methods
Targeted resequencing
With targeted sequencing or resequencing, a subset of genes or a genomic region of interest is isolated and sequenced, which can conserve lab resources.
Cancer genomics research
Our sequencing and microarray technologies support a broad range of cancer genomics research applications, from DNA to RNA analysis, epigenetics, and more.